LJG Equity Research

LJG Equity Research

CompanySymbolTitleAnalystSectorRatingTarget PriceDate
Liminal BioSciences Inc.LMNL-NASDAQHard-Fought Ryplazim FDA Approval Shifts Focus onto Pediatric Review Voucher and its Realizable ValueDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHoldUS$4.00Jun 7, 2021
Sernova Corp.SVA-TSXVCell Pouch Continues to Shine in Ongoing Phase I/II Islet Transplantation Testing ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$2.50Jun 7, 2021
Quipt Home Medical Corp.QIPT-TSXVFQ221 Data Reveals Sustained Revenue/EBITDA Growth Driven by Strong Execution on Acquisition Strategy - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$12.00Jun 2, 2021
Perimeter Medical Imaging AI, Inc. PINK-TSXVNo Major Surprises in FQ121 Data. OCT-Based Surgical Oncology Platform Advancing to Expectations ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$6.75Jun 1, 2021
CareRx CorporationCRRX-TSXIndustry-Leading Long-Term Care Pharmacy Provider Gets Even More Leading with Sizable Peer Acquisition - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$8.50May 20, 2021
Cipher Pharmaceuticals Inc.CPH-TSXStrong FQ121 Cash Flow Despite Sequential Absorica Royalty Softness, Offset by Epuris Strength - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$2.25May 17, 2021
Profound Medical Corp.PRN-TSXNo Major Commercial Activity for TULSA-PRO or Sonalleve, but Growth in Alliance Portfolio Portends Future Procedure Volume Growth - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuyUS$28.00May 17, 2021
Extendicare Inc.EXE-TSXStrong FQ121 AFFO & Payout Ratio From Strong Operations & Supplemental Funding, Shifting to HOLD on ValuationDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHold$8.25May 17, 2021
Appili Therapeutics Inc.APLI-TSXMixed Impact from PRESECO Trial Enrollment Extending into FQ321, but Unchanged View on Favipiravir Potential in COVID-19 Treatment ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$2.75May 17, 2021
Liminal BioSciences Inc.LMNL-NASDAQAnticipated Sale of Plasma Collection/Purification Business Focuses Firm on PBI-4050 Development in Fibrotic DiseaseDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHoldUS$4.00May 17, 2021
Medical Facilities CorporationDR-TSXSolid FQ121 Data Generates Attractive Pay-Out Ratio Despite Seasonal Softness - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$10.50May 14, 2021
IMV Inc.IMV-TSXNo Surprises in FQ121 Data ? Robust DPX Clinical Pipeline Still Led By DPX-Survivac Phase I/II Activities ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative BuyUS$8.25May 13, 2021
K-Bro Linen Inc.KBL-TSXPredictable Softness in FQ121 Hospitality Operations, But Evidence Of Pandemic Easing Starting To Materialize - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$47.50May 13, 2021
Oncolytics Biotech Inc.ONC-TSXIn-Line FQ121 Update, with Pelareorep Clinical Activities Still Driving Value in F2021/22 ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$8.50May 7, 2021
Antibe Therapeutics Inc.ATE-TSXStreamlining Corporate Structure to Fuse Patent-Owning Antibe Holdings with Antibe Therapeutics ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$17.75May 7, 2021
Profound Medical Corp.PRN-TSXTULSA-PRO Installed Base Should Accelerate with New Akumin Agreement - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuyUS$28.00May 6, 2021
Cipher Pharmaceuticals Inc.CPH-TSXBranded Absorica Sales Still Contributes Positively to Our EBITDA Projections Despite New Generic CompetitionDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$2.25Apr 30, 2021
Cardiol Therapeutics Inc.CRDL-TSXFormally Commences Enrollment In Phase II/III COVID-19 CardioRx Program ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$12.50Apr 28, 2021
K-Bro Linen Inc.KBL-TSXSubstantial Healthcare Linen/Laundry Processing Contract in Alberta Is Accretive to our Forecasts - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$47.50Apr 28, 2021
Perimeter Medical Imaging AI, Inc. PINK-TSXVRegulatory Update on OTIS/AI Platform Reflects Positively on Device Utility in Breast Tumor Margin AssessmentDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$6.75Apr 15, 2021
Theratechnologies Inc.TH-TSXPredictably Soft FQ121 Data on Pandemic Constraints, but Medical Prospects for Egrifta/Trogarzo Still Strong - HOLDDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHold$4.00Apr 14, 2021
Cardiol Therapeutics Inc.CRDL-TSXNo Major Surprises in Phase I CardiolRx Data, Phase II/III Testing in COVID-19 and Acute Myocarditis on the HorizonDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$12.50Apr 12, 2021
IMV Inc.IMV-TSXB-Cell Lymphoma Remains a Leading Indication for DPX-Survivac, with New Phase II Program on the HorizonDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$10.50Apr 7, 2021
Cardiol Therapeutics Inc.CRDL-TSXFQ420 Data Show R&D Expenses Accelerate With Phase II/III Acute Myocarditis/COVID-19 Trials On The Horizon ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$12.50Apr 5, 2021
Perimeter Medical Imaging AI, Inc. PINK-TSXVInitiating Coverage on Innovative Medical Imaging Firm With A Speculative BUY Rating Douglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$6.75Mar 29, 2021
IntelGenx Technologies Corp.IGX-TSXVFQ420 Update Shows VersaFilm Pipeline Still Well-Diversified into Multiple Medical Markets ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.00Mar 26, 2021
Liminal BioSciences Inc.LMNL-NASDAQFQ420 Update Reveals Sustained Focus on Fezagepras (PBI-4050), With Phase II IPF Testing On The Horizon - HOLDDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHoldUS$4.00Mar 26, 2021
Cardiol Therapeutics Inc.CRDL-TSXInitiating Coverage on Cardiovascular/Inflammatory Disease-Focused Cannabidiol Developer with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$12.50Mar 25, 2021
Cipher Pharmaceuticals Inc.CPH-TSXFQ420 Financial Data Clears Pathway for Pipeline BuildoutDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$2.50Mar 22, 2021
K-Bro Linen Inc.KBL-TSXFQ420 Data Reveals Strong EBITDA/Margin Despite Segment-Specific Softness In Hospitality Sector - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$43.50Mar 19, 2021
IMV Inc.IMV-TSXNo Major Surprises in FQ420 Data, DPX-Survivac Clinical Testing Marches on in Multiple Cancer IndicationsDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$10.50Mar 18, 2021
IntelGenx Technologies Corp.IGX-TSXVEquity Stake by ATAI Validates IntelGenx?s VersaFilm Plat-form in Emerging Psychedelic Therapy Niche ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.00Mar 16, 2021
Sernova Corp.SVA-TSXVCorporate Update Shows Us That Cell Pouch Development is Progressing to Our Expectations ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$2.50Mar 16, 2021
CareRx CorporationCRRX-TSXFavorable Trendlines on Both EBITDA and Margin in FQ420 Data, Expect Acquisitive Growth to Continue - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$7.00Mar 12, 2021
Medical Facilities CorporationDR-TSXSeasonally Strong FQ420 EBITDA as Expected, with Surgical Volumes Trending to Pre-Pandemic Level - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$10.50Mar 12, 2021
Oncolytics Biotech Inc.ONC-TSXIn-Line FQ420 Update, with Multiple Pelareorep Phase I/II Oncology Trials Marching to Data in F2021/22 ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$8.50Mar 8, 2021
Profound Medical Corp.PRN-TSXFQ420 Data Reveals Growing Traction for Ultrasound Tissue Ablation, Reimbursement Drivers on The Horizon - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuyUS$28.00Mar 4, 2021
PTQ-TSXVFQ121 Data Continues to Bode Well for Top-Performing Home Respiratory Equipment Developer - BUYBuy$3.25Mar 4, 2021
Extendicare Inc.EXE-TSXStrong FQ420 AFFO Mitigates Margin Softness in Core LTC-Homecare Operations, but Operating Metrics Trending Well into H121 - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$8.00Mar 1, 2021
Theratechnologies Inc.TH-TSXFQ420 Data Meet Expectations, Emphasis Shifts To Pending TH1902/Egrifta Clinical Trials, Shift To HOLD On ValuationDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHold$4.00Feb 26, 2021
Oncolytics Biotech Inc.ONC-TSXNew Preclinical Data Further Supports Pelareorep?s Utility in Combination Immuno-Oncology Therapy ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$8.50Feb 24, 2021
Cipher Pharmaceuticals Inc.CPH-TSXConsummates Co-Promotion Alliance for Part of the Correvio Acute Care Portfolio ? Speculative BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.75Feb 12, 2021
Antibe Therapeutics Inc.ATE-TSXRegional ATB-346/Otenaproxesul Alliance In China De-Risks Development In That Geography ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$17.75Feb 10, 2021
Theratechnologies Inc.TH-TSXTH1902 Grows in Status With FDA Fast Track Status Now Conferred, Phase I Solid Tumor Trial on the Horizon ? Speculative BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$4.00Feb 4, 2021
Appili Therapeutics Inc.APLI-TSXInitiating Coverage on Innovative Antifungal and Infectious Diseases Drug Developer with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$2.75Feb 3, 2021
PTQ-TSXVNew FL-Based Acquisition Fits Seamlessly into Existing Respiratory Equipment Foundation & on Attractive TermsBuy$3.25Feb 2, 2021
PTQ-TSXVNo Major Surprises in FQ420 Data for Top-Performing Home Respiratory Equipment Distributor - BUYBuy$3.25Feb 1, 2021
CareRx CorporationCRRX-TSXLeverages Leadership in the Canadian Long-Term Care Rx Universe with New Acquisitive Growth - BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$7.00Jan 26, 2021
CareRx CorporationCRRX-TSXMitigation of Long-Term Care Rx Funding Compression in Ontario Reduces Risk to Our Revenue/EBITDA ForecastsDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$6.50Jan 18, 2021
Sernova Corp.SVA-TSXVTarget Increase on Phase I Cell Pouch Update Supporting Device Utility in Type I Diabetes ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$2.50Jan 18, 2021
Antibe Therapeutics Inc.ATE-TSXInitiating Coverage on Innovative Pain Therapy Developer with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$15.00Jan 11, 2021
Cipher Pharmaceuticals Inc.CPH-TSXInitiating Coverage on Dermatology-Focused Specialty Pharma Firm with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.75Jan 11, 2021
IntelGenx Technologies Corp.IGX-TSXVNew Purchase Order Provides Visibility on Revenue Trac-tion for Thin-Film Cannabis Franchise in F2021 ? Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.00Jan 7, 2021
Theratechnologies Inc.TH-TSXPandemic Minimally Impede FQ420 Egrifta-Trogarzo Sales, Start Of NASH/Oncology Trials is Pending - Spec BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$4.00Jan 7, 2021
Profound Medical Corp.PRN-TSXInitiating Coverage with a BUY Rating on Leading Ultrasound-Based Tissue Ablation Platform DeveloperDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$36.50Dec 21, 2020
PTQ-TSXVInitiating Coverage on US-Based Medical Equipment Distributor/Home Healthcare Services FirmBuy$3.25Dec 21, 2020
Theratechnologies Inc.TH-TSXInitiating Coverage on Innovative HIV Drug Developer with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$4.00Dec 21, 2020
CareRx CorporationCRRX-TSXFQ320 Update Again Documents Profitable Execution on Long-Term Care Pharmacy Operations ? BUYDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$6.50Dec 15, 2020
Medical Facilities CorporationDR-TSXInitiating Coverage on Profitable US-Based Surgical Hospital Operator with a BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$10.50Dec 15, 2020
Extendicare Inc.EXE-TSXInitiating Coverage on Leading Eldercare Services Provider with a BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$8.00Dec 15, 2020
IntelGenx Technologies Corp.IGX-TSXVInitiating Coverage on Oral Drug Delivery Technology SolutionsDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.00Dec 15, 2020
IMV Inc.IMV-TSXInitiating Coverage on Innovative Immune Therapy Developer With A BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$10.50Dec 15, 2020
K-Bro Linen Inc.KBL-TSXInitiating Coverage on Industry-Leading Healthcare-Hospitality Services Provider with a BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologyBuy$42.00Dec 15, 2020
Liminal BioSciences Inc.LMNL-NASDAQInitiating Coverage on Plasma Protein & Anti-Fibrotic Drug Developer with a HOLD RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologyHoldUS$4.00Dec 15, 2020
Oncolytics Biotech Inc.ONC-TSXInitiating Coverage on Clinical-Stage Oncolytic Virus Developer with a Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$8.50Dec 15, 2020
Sernova Corp.SVA-TSXVInitiating Coverage on Emerging Regenerative Medicine Innovator With A Speculative BUY RatingDouglas W. Loe, PhD MBAHealthcare & BiotechnologySpeculative Buy$1.00Dec 15, 2020